Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$34.41 USD
+0.37 (1.09%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $34.42 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.41 USD
+0.37 (1.09%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $34.42 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Zacks News
PGRE vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PGRE vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PGRE or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
PGRE vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 4.62% and 1.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
National Storage (NSA) Lags Q1 FFO Estimates
by Zacks Equity Research
National Storage (NSA) delivered FFO and revenue surprises of -1.64% and 0.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Regency Centers (REG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers and strategic acquisitions are likely to have benefited the company's Q1 earnings. However, higher interest rates might have ailed.
Community Healthcare Trust (CHCT) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of -1.67% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Arbor Realty (ABR) Retain Its Beat Streak in Q1 Earnings?
by Zacks Equity Research
While growth in servicing revenues is expected to have aided Arbor Realty's (ABR) Q1 earnings, a decline in revenues from mortgage servicing rights is likely to have been a headwind.
What's in Store for Federal Realty (FRT) This Earnings Season?
by Zacks Equity Research
Federal Realty's (FRT) first-quarter results are likely to gain from the healthy leasing activity, though tenant bankruptcies and higher interest expenses act as dampeners.
ESRT vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ESRT vs. OHI: Which Stock Is the Better Value Option?
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
PGRE vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
PGRE or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
RLJ vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
RLJ vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Q4 FFO Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 1.49% and 1.04%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
RLJ vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RLJ vs. OHI: Which Stock Is the Better Value Option?
Gear Up for Omega Healthcare Investors (OHI) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Omega Healthcare Investors (OHI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Should iShares Morningstar Small-Cap Value ETF (ISCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for ISCV
Omega Healthcare Investors (OHI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Omega Healthcare Investors (OHI) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.